Pancreatic Cancer Clinical Trials in Hangzhou, Zhejiang
17 recruitingHangzhou, Zhejiang, China
Showing 1–17 of 17 trials
Recruiting
Phase 2
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
Pancreatic CancerSolid TumorKRAS P.G12C
Allist Pharmaceuticals, Inc.88 enrolled31 locationsNCT06008288
Recruiting
Not Applicable
Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"
Pancreatic Cancer
Zhejiang University100,000 enrolled1 locationNCT06643715
Recruiting
Phase 3
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
Pancreatic Cancer
Akeso999 enrolled3 locationsNCT06953999
Recruiting
Phase 2
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.12 enrolled1 locationNCT07006077
Recruiting
Phase 1Phase 2
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Pancreatic CancerPD-1 InhibitorPD-L1+2 more
Zhejiang Provincial People's Hospital10 enrolled1 locationNCT07312422
Recruiting
Phase 2
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
Advanced Pancreatic Cancers
Zhejiang University64 enrolled2 locationsNCT06770439
Recruiting
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Liver CancerPancreatic CancerBiliary Tract Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University1,608 enrolled1 locationNCT06139042
Recruiting
Early Phase 1
A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
Pancreatic Cancer Non-resectable
Zhejiang University30 enrolled1 locationNCT06503497
Recruiting
Early Phase 1
Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer
Pancreatic Cancer Non-resectable
Zhejiang University20 enrolled1 locationNCT06478459
Recruiting
Phase 2
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
Akeso78 enrolled7 locationsNCT05859750
Recruiting
Phase 2
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital57 enrolled1 locationNCT06722911
Recruiting
Phase 1Phase 2
CTS2190 Phase I /II Clinical Study in Patients
Pancreatic CancerSolid TumorsNon-small Cell Lung Cancer
CytosinLab Therapeutics Co., Ltd.224 enrolled2 locationsNCT06224387
Recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Pancreatic Cancer
CARsgen Therapeutics Co., Ltd.20 enrolled8 locationsNCT05911217
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Phase 2Phase 3
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
Metastatic Pancreatic Cancer
1Globe Health Institute LLC336 enrolled38 locationsNCT03721744
Recruiting
Phase 2
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
Pancreatic CancerChemotherapy Effect
Second Affiliated Hospital, School of Medicine, Zhejiang University480 enrolled1 locationNCT03498326